Mineralocorticoid receptor antagonists in heart failure with preserved (and mildly reduced) ejection fraction: a comparative review of spironolactone and finerenone

Heart failure with preserved ejection fraction (HFpEF) accounts for approximately half of all heart failure presentations and remains associated with substantial mortality, ranging from 15% at 1 year to nearly 75% within 5-10 years following hospitalization. Mineralocorticoid receptor antagonists (...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Hafsa Azam, Syed Sarmad Javaid, Mahir Karakas
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	PAGEPress Publications 2026-07-01
Edice:	Global Cardiology
Témata:	HFpEF spironolactone finerenone mineralocorticoid receptor antagonists
On-line přístup:	https://www.globalcardiology.info/site/article/view/110
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!